Back to Research Hub
Regencell Bioscience Holdings Limited
RGC
$19.99-1.40 (-6.55%)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
StreetsValue research for Regencell Bioscience Holdings Limited (RGC)
Members get the full report for Regencell Bioscience Holdings Limited: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.